Jeffrey Shuren In a statement, published on the its website, the FDA has outlined the steps it is taking to update its Medical Device Reporting (MDR) programme—one of the tools the FDA uses to monitor device performance, detect potential device-related safety concerns or signals and contribute to the benefit-risk assessment of these [...]